Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing
The $TRILLION Opportunity in CRISPR & DNA Sequencing Technologies
Smart Money
Nigam Arora: The Coming “Canadian Marijuana Stocks Massacre” (and some good news)
Nigam Arora: The Coming “Canadian Marijuana Stocks Massacre”. Nigam discusses his long term outlook for cannabis stocks… He expects cannabis stocks focused on the Canadian market to lose 90% value, as market realities set in. […]
Investing Strategy
Paul Tudor Jones on Recession Risks
Paul Tudor Jones “Hopefully I will be REALLY short” Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover […]
Healthcare
CytoDyn (OTC: CYDY)Reports Significant Reduction in Breast Cancer Tumor Metastasis in Preclinical Study and Requests FDA Fast Track Designation for Leronlimab (PRO 140) in Metastatic-Triple Negative Breast Cancer (mTNBC)
VANCOUVER, Washington, March 11, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that leronlimab (PRO 140), […]